
Asclemed: Multiple Lidocaine Hcl Injections
Asclemed recalls Accucaine kits and Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL ampules due to lack of sterility assurance.
Do not use the recalled Accucaine kits or Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampules. Contact Asclemed USA Inc. for instructions on returning the product and obtaining a refund or replacement.
Why it was recalled
Asclemed USA Inc. is recalling Accucaine kits containing Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampules, due to a lack of assurance of sterility. The recall affects the Accucaine kit and the Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Strength: 10 mg
| Product | Lot code | NDC / UPC | Recall # |
|---|---|---|---|
| Accucaine, Kit contains: Lidocaine HCl Injection USP, 1% ( | AE3102, 121924X2, 022525X4, 033125X1, 030426X2, 033125X2, 041725X3, 061225X1, 072225X3, 080525X6, 080525X7, 080525X8, 091225X1, 100225X2, 100625X1, 122225X4, 010626X3, 041326X4, 2026 | NDC 76420-715-01 | D-0658-2026 |
| Lidocaine HCl Injection USP, 1% ( | AE3102, 031926L01, 032026A01, 2026 | NDC 85766-187-01 | D-0659-2026 |
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Sterility Failure recalls
Other recent recalls from Asclemed USA Inc.
Editorial summary by Recall Canary · summary updated 2026-09-03 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification
